Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

News

  • Work with D-Wave Cited as Changing Drug Discovery and Quantum Computing
    March 17th, 2023· 1.2 min·
    Work with D-Wave Cited as Changing Drug Discovery and Quantum Computing

    Recently, POLARISqb has been in the news for the revolutionary work that

  • PolarisQB talks with QuBites from Valorem Reply
    January 26th, 2023· 0.7 min·
    PolarisQB talks with QuBites from Valorem Reply

    We were excited to engage in this fantastic conversation with Rene Schulte

  • Quantum Computing for the Real World: Ars Technica writes about PolarisQB and D-Wave
    January 20th, 2023· 2.9 min·
    Quantum Computing for the Real World: Ars Technica writes about PolarisQB and D-Wave

    Just as the team was returning from some well-deserved time off

  • PolarisQB and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
    August 10th, 2022· 3.1 min·
    PolarisQB and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI

    Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based

  • Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech
    February 3rd, 2022· 3.1 min·
    Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech

    February 3, 2022, Allosteric Bioscience, Inc., a company founded in 2021 to

  • PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
    January 5th, 2022· 1.9 min·
    PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies

    Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated

  • PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million
    September 30th, 2021· 1.3 min·
    PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million

    PolarisQB, the Durham based developer of the world’s first drug discovery software

  • Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation
    July 8th, 2021· 1 min·
    Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation

    Last year Polarisqb  began our journey to revolutionize the world of drug

  • Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases
    June 4th, 2021· 2.5 min·
    Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases

    PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial

  • PolarisQB Announce Hiring of Pharmacologist Ian Reynolds
    May 10th, 2021· 2.2 min·
    PolarisQB Announce Hiring of Pharmacologist Ian Reynolds

    Polarisqb  is proud to add Dr. Ian Reynolds, a world renowned expert

Previous234Next
Search
Recent Posts
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
  • Combinatorial Optimization vs. Physical Simulation January 19, 2025
  • Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats January 12, 2025
Categories
  • Blog (14)
  • News (43)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top